Cargando…

Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey

BACKGROUND: Patients with bronchiectasis are at increased risk of developing non-tuberculous mycobacteria lung disease (NTM-LD), and published guidelines recommend regular testing for NTM infection in this patient population. OBJECTIVE: This study aimed to survey physicians managing patients with br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner, Dirk, van Ingen, Jakko, van der Laan, Roald, Obradovic, Marko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Respiratory Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204844/ https://www.ncbi.nlm.nih.gov/pubmed/32332023 http://dx.doi.org/10.1136/bmjresp-2019-000498

Ejemplares similares

Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK
por: Lipman, Marc, et al.
Publicado: (2020)

Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts
por: McDonnell, M J, et al.
Publicado: (2016)

Global survey of physician testing practices for nontuberculous mycobacteria
por: Loebinger, Michael R., et al.
Publicado: (2023)

Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections
por: Chalmers, James D., et al.
Publicado: (2021)

The effects of sildenafil on ciliary beat frequency in patients with pulmonary non-tuberculous mycobacteria disease: phase I/II trial
por: Fowler, Cedar, et al.
Publicado: (2020)

British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together
por: Lim, W S, et al.
Publicado: (2015)

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
por: Ruth, Mike Marvin, et al.
Publicado: (2020)

Molecular epidemiology and clinical impact of rhinovirus infections in adults during three epidemic seasons in 11 European countries (2007–2010)
por: Zlateva, Kalina T, et al.
Publicado: (2020)

Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021: a systematic review and meta-analysis
por: Zhou, Yunchun, et al.
Publicado: (2022)

British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease
por: Smith, David, et al.
Publicado: (2020)

Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis
por: He, Min, et al.
Publicado: (2020)

Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial
por: van den Berk, Inge A H, et al.
Publicado: (2023)

Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19
por: Saris, Anno, et al.
Publicado: (2021)

Analyses of abdominal adiposity and metabolic syndrome as risk factors for respiratory distress in COVID-19
por: van Zelst, Cathelijne M, et al.
Publicado: (2020)

Bronchiectasis and the risk of cardiovascular disease: a population-based study
por: Navaratnam, Vidya, et al.
Publicado: (2017)

Utility of a personalised Bronchiectasis Action Management Plan (BAMP) for children with bronchiectasis: protocol for a multicentre, double-blind parallel, superiority randomised controlled trial
por: Marchant, Julie M, et al.
Publicado: (2021)

Low utilisation of bronchoscopy to assess COVID-19 respiratory infection: a multicenter experience
por: Mahmood, Kamran, et al.
Publicado: (2021)

Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data
por: Hedberg, Pontus, et al.
Publicado: (2022)

Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
por: Zhou, Guiling, et al.
Publicado: (2023)

Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)
por: Nguyen-Van-Tam, J S, et al.
Publicado: (2010)

Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults
por: Bewick, Thomas, et al.
Publicado: (2011)

Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study
por: Veziris, Nicolas, et al.
Publicado: (2021)

Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK
por: Myles, Puja R, et al.
Publicado: (2012)

Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis
por: Morton, Miranda, et al.
Publicado: (2023)

Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study
por: Wang, Hong, et al.
Publicado: (2018)

Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in the Netherlands based on medication dispensing data
por: Hoefsloot, W, et al.
Publicado: (2023)

Metagenomic next-generation sequencing assistance in identifying non-tuberculous mycobacterial infections
por: Wang, Shilei, et al.
Publicado: (2023)

High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening
por: Oni, Tolu, et al.
Publicado: (2011)

Diagnostic importance of pulmonary interleukin-1β and interleukin-8 in ventilator-associated pneumonia
por: Conway Morris, Andrew, et al.
Publicado: (2010)

Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation
por: Wang, H, et al.
Publicado: (2009)

Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
por: Lauder, Sarah N, et al.
Publicado: (2011)

Bronchoalveolar CD4(+) T cell responses to respiratory antigens are impaired in HIV-infected adults
por: Jambo, Kondwani C, et al.
Publicado: (2011)

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality
por: Ewig, S, et al.
Publicado: (2009)

Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy
por: Spann, Kirsten M, et al.
Publicado: (2014)

Differential response to bacteria, and TOLLIP expression, in the human respiratory tract
por: Moncayo-Nieto, Olga Lucia, et al.
Publicado: (2014)

Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease
por: Fujita, Kohei, et al.
Publicado: (2014)

Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia
por: Dwyer, Richard, et al.
Publicado: (2014)

Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
por: Garnett, James P, et al.
Publicado: (2013)

Microbial communities in the respiratory tract of patients with interstitial lung disease
por: Garzoni, Christian, et al.
Publicado: (2013)

Perceptions of medical students towards antibiotic prescribing for upper respiratory tract infections in Saudi Arabia
por: Harakeh, Steve, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_unsedfhlc3838ucqd8b0rk06pe